214 related articles for article (PubMed ID: 8040268)
1. Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor.
Watson JB; Getzler SB; Mosher DF
J Clin Invest; 1994 Jul; 94(1):261-8. PubMed ID: 8040268
[TBL] [Abstract][Full Text] [Related]
2. Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor.
Brown KJ; Parish CR
Biochemistry; 1994 Nov; 33(46):13918-27. PubMed ID: 7524669
[TBL] [Abstract][Full Text] [Related]
3. Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells.
Nugent MA; Karnovsky MJ; Edelman ER
Circ Res; 1993 Dec; 73(6):1051-60. PubMed ID: 8222077
[TBL] [Abstract][Full Text] [Related]
4. Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells.
Skaletz-Rorowski A; Schmidt A; Breithardt G; Buddecke E
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1063-9. PubMed ID: 8696947
[TBL] [Abstract][Full Text] [Related]
5. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
Krufka A; Guimond S; Rapraeger AC
Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
[TBL] [Abstract][Full Text] [Related]
6. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response.
Fannon M; Forsten KE; Nugent MA
Biochemistry; 2000 Feb; 39(6):1434-45. PubMed ID: 10684625
[TBL] [Abstract][Full Text] [Related]
7. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA.
Aviezer D; Iozzo RV; Noonan DM; Yayon A
Mol Cell Biol; 1997 Apr; 17(4):1938-46. PubMed ID: 9121441
[TBL] [Abstract][Full Text] [Related]
8. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
Brown KJ; Hendry IA; Parish CR
J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
[TBL] [Abstract][Full Text] [Related]
9. Endothelial proteoglycans inhibit bFGF binding and mitogenesis.
Forsten KE; Courant NA; Nugent MA
J Cell Physiol; 1997 Aug; 172(2):209-20. PubMed ID: 9258342
[TBL] [Abstract][Full Text] [Related]
10. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.
Klagsbrun M
Semin Cancer Biol; 1992 Apr; 3(2):81-7. PubMed ID: 1378313
[TBL] [Abstract][Full Text] [Related]
11. Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C.
Bashkin P; Neufeld G; Gitay-Goren H; Vlodavsky I
J Cell Physiol; 1992 Apr; 151(1):126-37. PubMed ID: 1313817
[TBL] [Abstract][Full Text] [Related]
12. Degradation of cell surface heparan sulfates decreases the high affinity binding of basic FGF to endothelial cells, but not to FRTL-5 rat thyroid cells.
Emoto N; Isozaki O; Ohmura E; Shizume K; Tsushima T; Demura H
Thyroid; 1995 Dec; 5(6):455-60. PubMed ID: 8808095
[TBL] [Abstract][Full Text] [Related]
13. Sulfate moieties in the subendothelial extracellular matrix are involved in basic fibroblast growth factor sequestration, dimerization, and stimulation of cell proliferation.
Miao HQ; Ishai-Michaeli R; Atzmon R; Peretz T; Vlodavsky I
J Biol Chem; 1996 Mar; 271(9):4879-86. PubMed ID: 8617759
[TBL] [Abstract][Full Text] [Related]
14. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
15. Human recombinant insulin-like growth factor I and -II stimulate the expression of basic fibroblast growth factor but suppress the division of bovine coronary smooth muscle cells.
Schriever C; Schmidt A; Breithardt G; Buddecke E
Atherosclerosis; 1996 May; 122(2):255-63. PubMed ID: 8769688
[TBL] [Abstract][Full Text] [Related]
16. Possible mechanism for lead inhibition of vascular endothelial cell proliferation: a lower response to basic fibroblast growth factor through inhibition of heparan sulfate synthesis.
Fujiwara Y; Kaji T
Toxicology; 1999 Apr; 133(2-3):147-57. PubMed ID: 10378481
[TBL] [Abstract][Full Text] [Related]
17. CDGF (chicken embryo fibroblast-derived growth factor) is mitogenically related to TGF-beta and modulates PDGF, bFGF, and IGF-I action on sparse NIH/3T3 cells.
Geistlich A; Gehring H
Exp Cell Res; 1993 Feb; 204(2):329-35. PubMed ID: 8440329
[TBL] [Abstract][Full Text] [Related]
18. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
Miao HQ; Fritz TA; Esko JD; Zimmermann J; Yayon A; Vlodavsky I
J Cell Biochem; 1995 Feb; 57(2):173-84. PubMed ID: 7759555
[TBL] [Abstract][Full Text] [Related]
20. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells.
Jayson GC; Gallagher JT
Br J Cancer; 1997; 75(1):9-16. PubMed ID: 9000592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
